Journal of Southern Medical University ›› 2013, Vol. 33 ›› Issue (06): 804-.

Previous Articles     Next Articles

Roles of miR-590-5p and miR-590-3p in the development of hepatocellular carcinoma

  

  • Online:2013-06-20 Published:2013-06-20

Abstract: Objective To study the effect of the two arms of miR-590, miR-590-5p and miR-590-3p, on hepatoma cell
proliferation and their roles in tumor development. Methods We analyzed and verified the expression pattern of miR-590 in
liver cancer specimens and cell lines by miRNA microarrays and QPCR. MiR-590 mimic or inhibitor was transfected into
normal liver cells or liver cancer cells via liposome, and the changes in cell proliferation and survival were determined by MTT
assay and soft agar colony formation assay. The target genes of miR-590-5p and miR-590-3p were predicated with Targetscan
and validated by luciferase reporter system and Western blotting. Results The expressions of miR-590-5p and miR-590-3ps
were up-regulated in 3 hepatocellular carcinoma (HCC) tissues and their synchronization was significantly up-regulated in 8
out of 10 HCC tissues as compared with the adjacent tissues. QPCR further showed that miR-590-5p/3p was up-regulated in 3
HCC cell lines (HepG2, Hep3B, and Huh7) in comparison with the normal liver cell line L-O2. L-O2 cells over-expressing
miR-590-5p and miR-590-3p exhibited significantly increased proliferation (P<0.05), while down-regulation of miR-590-5p and
miR-590-3p caused significantly suppressed proliferation in HepG2, Hep3B, and Huh7 cells. Targetscan predicted PDCD4 and
PTEN as the potential target genes of miR-590-5p and miR-590-3p, which was verified by luciferase reporter system and
Western blotting. miR-590-3p was found to activate PI3K-AKT signaling pathway by down-regulating PTEN to promote
AKT1-S473 phosphorylation. Conclusion MiR-590 is an important tumorigenic factor for HCC, and its two arms can both
promote tumorigenesis by regulating the expression of their target tumor suppressor gene, PDCD4 and PTEN, to promote
HCC cell proliferation and survival and activate the core tumor signal pathway PI3K-AKT.